CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
Lefort, S, Thuleau, A, Kieffer, Y, Sirven, P, Bieche, I, Marangoni, E, Vincent-Salomon, A, Mechta-Grigoriou, F
Published in Oncogene (02.03.2017)
Published in Oncogene (02.03.2017)
Get full text
Journal Article
A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer
Faucheux, L., Grandclaudon, M., Perrot-Dockès, M., Sirven, P., Berger, F., Hamy, A.S., Fourchotte, V., Vincent-Salomon, A., Mechta-Grigoriou, F., Reyal, F., Scholer-Dahirel, A., Guillot-Delost, M., Soumelis, V.
Published in Oncoimmunology (02.09.2019)
Published in Oncoimmunology (02.09.2019)
Get full text
Journal Article
The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes
Immonen, A., Kinnunen, T., Sirven, P., Taivainen, A., Houitte, D., Peräsaari, J., Närvänen, A., Saarelainen, S., Rytkönen-Nissinen, M., Maillere, B., Virtanen, T.
Published in Clinical and experimental allergy (01.06.2007)
Published in Clinical and experimental allergy (01.06.2007)
Get full text
Journal Article